John Marotta is a Board member at Lunaphore and the President & CEO of Epredia, a PHC Group company focused on anatomical pathology. In addition to his role at Epredia, John is also a Corporate Officer for the PHC Group, and the Co-Domain Head for the Life Sciences and Diagnostics Domain. PHC Group is owned by KKR, as the largest shareholder.
Prior to joining Epredia, John’s most recent role was Senior Vice President of Supply Chain, Procurement, Real Estate, IT, Envista Business Systems and the LatAm Region. John has held senior level positions as a former Vice President and General Manager, President and CEO, Board member and other commercial and operations roles in companies such as Danaher, Cardinal Health and Emerge Medical. John began his career at Johnson & Johnson operating companies, Janssen Pharmaceutica and DePuy Synthes Orthopaedics, where he held various commercial roles.